Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Cancer Medicine|January 23, 2021
Real world outcomes of combination and timing of immunotherapy with radiotherapy for melanoma with brain metastasesJustin T Moyers, Esther G Chong, Jiahao Peng, et al.
Cancer Metastasis Reviews|April 27, 2022
The cure from within? a review of the microbiome and diet in melanomaPriyanka Kumar, Danielle Brazel, Julia DeRogatis, et al.
Transplantation and Cellular Therapy|March 15, 2025
Defining the Quality Attributes for Tumor-Infiltrating Lymphocyte Medicinal ProductsJustin J Lievense, Cynthia Nijenhuis, Inge Jedema, et al.
Oral Oncology|January 14, 2026
Incorporation of grade into stage in oral cavity squamous cell carcinoma: A novel staging schemaAllen S Ho, Michael Luu, Daniel Manzoor, et al.
Oral Oncology|June 23, 2024
Patient perceptions underlying ctDNA molecular surveillance for HPV(+) oropharyngeal squamous cell carcinomaAmanda J Bastien, Jewel Ng, Iris Cong, et al.
JCO Precision Oncology|April 30, 2026
Pertuzumab and Trastuzumab in Patients With <i>ERBB2/3</i>-Altered Urothelial or Ovary/Fallopian Tube Cancer: Results From the Targeted Agent and Profiling Utilization Registry StudyJohn K Chan, Michael Rothe, Elizabeth Garrett-Mayer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2022
Examining Stripes on a Herd of Zebras: Impact of Genomic Matching for Ultrarare Sarcomas in Phase 1 Clinical Trials (SAMBA 102)Justin T Moyers, Roberto Carmagnani Pestana, Jason Roszik, et al.
JCO Precision Oncology|April 22, 2026
Temsirolimus in Patients With Solid Tumors With <i>PIK3CA</i> Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) StudyEvan Pisick, Michael Rothe, Elizabeth Garrett-Mayer, et al.
JCO Precision Oncology|January 15, 2026
Olaparib in Patients With Solid Tumors With <i>ATM</i> Alterations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) StudyDaniel R Carrizosa, Michael Rothe, Pam K Mangat, et al.
JCO Oncology Practice|December 4, 2025
Evolving Use of Circulating Tumor DNA for HPV+ Oropharyngeal Carcinoma: Consensus Recommendations From the California Head and Neck ConsortiumAllen S Ho, Justin T Moyers, Shirin Attarian, et al.
Pageof 3